Presenters
Nutrition Specialist
Prof. Stephan Jacob, MD
Course Details
The aim of this webinar is to provide updates on how Linagliptin has brought improvements in diabetes care over the last 10 years. It will discuss the clinical trials of linagliptin – its efficacy, cardiovascular and renal safety and convenience across a broad range of T2D patients, and how it helps make the management of a complex disease more simple
0.75 CPD Point upon completion.
Estimated time of Completion: 45 mins
Course Outline 10 Years of Simplicity in Managing Type 2 Diabetes
- Type 2 diabetes is a life-threatening disease with multiple risk factors
- Type 2 diabetes is a disease which requires a lifelong management
- SIMPLICITY and SAFETY is a must
- Type 2 diabetes requires individualized and safe glucose-lowering therapy in the context of comorbidities
- Newer agents including DPP4i are SIMPLE and have provided SAFETY in different (high) risk groups
- Course Evaluation
PC-PH-104468 / December 2022